ST2 and Galectin-3: Ready for Prime Time? - Wikidata - wikimedia - TriplyDB

ST2 and Galectin-3: Ready for Prime Time?

ST2 and Galectin-3: Ready for Prime Time?

http://www.wikidata.org/entity/Q38816590

about

ST2 and Galectin-3: Ready for Prime Time?

http://www.wikidata.org/entity/Q38816590

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

ST2 and Galectin-3: Ready for Prime Time?

@en

type

label

ST2 and Galectin-3: Ready for Prime Time?

@en

prefLabel

ST2 and Galectin-3: Ready for Prime Time?

@en

P1433

Q38816590-E68D9068-9A5D-47E0-AF0B-D97F84A3BC3E

P1476

Q38816590-61BB3566-59BD-45D7-9018-A8B6068E4FD0

P2093

Q38816590-29D2B631-3DCC-4BE6-BE6F-FA1A2A08BCB7

Q38816590-4F7AAA3C-1383-445C-8A53-C38ADE34272D

Q38816590-A2F5FFB2-8F91-42B6-B80B-25881C357D3E

P2860

Q38816590-14B489D4-0F82-4742-AA51-B2FB1B8995F7

Q38816590-14B93A40-AE2A-4109-93E4-10B9D066BC47

Q38816590-1C17B679-D583-41A9-BA53-613F95A95723

Q38816590-1F01FB59-9B62-4876-9ACE-FA49DC920F36

Q38816590-2507B604-92B2-47FE-A92C-A378F5B6DE8E

Q38816590-280E511D-AB42-4808-9330-C1ABCB8E35F4

Q38816590-288032F3-5C6D-4BC0-B861-2E4FA5352BE7

Q38816590-2B4A54EB-0677-4C48-A1BB-2144FCF4351B

Q38816590-2D1F2077-58D4-432B-B8D1-B176DD745C38

Q38816590-3AE4A3FC-FBD7-4ADA-AE19-FEC51C92CCDA

P304

Q38816590-7627EC1A-099B-4268-BA54-521823DF48B2

P31

Q38816590-8A566D20-F375-44EF-82E2-40E79AAA9253

P433

Q38816590-AA0D2063-AA74-4B27-85AF-C14EB9ABCE71

P478

Q38816590-555C078D-CE38-4381-B096-5ECBB1D4540B

P577

Q38816590-05EA0EEB-DED3-4D05-B0D6-C081666945CF

P698

Q38816590-31ADE3C8-43D8-4A22-9B8D-79E77A5347E9

P932

Q38816590-432704DC-B23D-4CE4-A5C7-A63CA6B2E353

P1433

P1476

ST2 and Galectin-3: Ready for Prime Time?

@en

P2093

A Rogier van der Velde

http://www.w3.org/2001/XMLSchema#string

Rudolf A de Boer

http://www.w3.org/2001/XMLSchema#string

Wouter C Meijers

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization

State of the Art: Newer biomarkers in heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study

Epidemiology, aetiology, and prognosis of heart failure.

P304

238-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27683537

http://www.w3.org/2001/XMLSchema#string

P932

5009948

http://www.w3.org/2001/XMLSchema#string